Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. The company’s diabetes segment lags behind competitors like DexCom and Abbott due to ...

They're healthy companies that should continue to pay durable dividends in the decades ahead, making them great income ...

ZBH Zimmer Biomet Holdings, Inc.

“Short of that, these steps by Medtronic will help medical personnel evaluate readings which can be artificially high for people with darker skin pigmentation.” The FDA’s device center has been ...

GALWAY, Ireland, Nov. 5, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of ...

According to the evidence presented at trial, Doron Tavlin learned about a secret, pending acquisition by Medtronic of Mazor Robotics, where he worked as vice president of business development ...